Our portfolio
SD Biosensor - COVID-19 Rapid Diagnostic Test

LMIC access to COVID-19 rapid diagnostic tests

SD Biosensor received foundation support to make its COVID-19 Ag Rapid Diagnostic Test available to low- and middle-income countries. High-quality, affordable tests with results available in 15–30 minutes are a critical tool to fight the pandemic.
Website
  • Domain
    Healthcare Delivery
  • Investment type
    Volume guarantee
  • Status
    Exit
  • Initial investment
    Private
  • Partnered in
    2020
  • Investment lead
    Natalie Revelle
  • Headquarters
    South Korea
  • Program strategy
    COVID-19 Response
Portfolio news
Global partnership to make available 120 million affordable, quality COVID-19 rapid tests for low- and middle-income countries

More about our work

Our focus

Our six domains of focus comprise 40+ program strategies across the Foundation’s nearly $9B annual charitable support.

Investment approach

Fostering partnerships with the private sector to leverage groundbreaking global innovations for societal good.

Our team

We bring depth of experience to every investment, with a proven track record across sectors and scale.